✦ LIBER ✦

Grading of Severe Follicular Rash in Patients Receiving EGFR Inhibitors

✍ Scribed by Ausilia Maria Manganoni; Camillo Farisoglio; Vittorio Ferrari; Alberto Zaniboni; Giordano Beretta; Fausto Meriggi; Piergiacomo Calzavara-Pinton

Book ID: 111773257
Publisher: Springer
Year: 2009
Tongue: English
Weight: 127 KB
Volume: 17
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-009-0714-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of dermatological toxicities

Management of dermatological toxicities in patients receiving EGFR inhibitors

✍ Kathy Lynch 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 916 KB

Management of EGFR-inhibitor associated

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

✍ Peter Arne Gerber, Stephan Meller, Tatiana Eames, Bettina Alexandra Buhren, Holg 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 302 KB

Relationship between skin rash and outco

Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: A literature-based meta-analysis of 24 trials

✍ Petrelli, Fausto; Borgonovo, Karen; Cabiddu, Mary; Lonati, Veronica; Barni, Sand 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Prevalence of Potentially Severe Drug-Dr

Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy

✍ R??tz Bravo, Alexandra E; Tchambaz, Lydia; Kr??henb??hl-Melcher, Anita; Hess, Lo 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 136 KB

Long-term Benefits of Angiotensin-Conver

Long-term Benefits of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Severe Immunoglobulin A Nephropathy: A Comparison to Patients Receiving Treatment With Other Antihypertensive Agents and to Patients Receiving No Therapy

✍ Cattran, Daniel C.; Greenwood, Celia; Ritchie, Susan 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 703 KB

Risk factors and occurrence of rash in H

Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mμL)

✍ M Floridia; R Bucciardini; V Fragola; CM Galluzzo; G Giannini; MF Pirillo; R Ami 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB